Another key plank of Amgen’s remarkable growth in the 1990s and early 2000s was through mergers and acquisitions. It focused on other innovative biotechnology companies, acquiring Synergen in ...

Amgen's dividend yield remains attractive, with a moderate payout ratio and strong free cash flow. Click here to see why AMGN ...

Amgen’s acquisition will give the company access to Reykjavik, DeCODE’s technology used to sequence human genomes. Amgen plans to develop treatments targeting the defective genes found using ...

The company has a robust earnings surprise history. It has surpassed ... a significant surge in volumes and the acquisition of Horizon Therapeutics, Amgen’s total revenues surged 23.2% year ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

Amgen reported strong fourth-quarter earnings, driven by strategic acquisitions and robust product sales growth. Amgen specializes in biotechnology as it seeks to advance medical therapeutics.

Today, Benzinga 's options scanner spotted 28 uncommon options trades for Amgen. This isn't normal. The overall sentiment of these big-money traders is split between 39% bullish and 46%, bearish. Out ...

Recent attention includes strategic acquisitions to bolster its presence in rare disease treatments. Success factors for Amgen include its ability to deliver novel therapeutics and manage ...

Amgen stock prices rose nearly 1.5% in the trading session following the release of its mixed Q3 results on Oct. 30. Driven by a significant surge in volumes and the acquisition of Horizon ...